Industry News
Human Breast Tumor Evasion Of The Antitumor Immune Response
Aug 16, 2011
The main cause of death in women with breast cancer is spread of the original tumor to distant sites, a process known as metastasis. Immune cells known as NK cells help limit tumor progression and metastasis in animal models... Read More
New Tool Matches Medical Treatment Data To New Cancer Cases To Improve Prostate Cancer Treatment
Aug 16, 2011
Prostate cancer, the most common form of cancer in U.S. men, is also one of the most treatable: 90 percent of patients who undergo intensity modulated radiation therapy (IMRT) in the early stages are disease free after five years, according to the journal Seminars in Radiation Oncology... Read More
Triple Therapy Leads To Remission In Cutaneous Lymphoma
Aug 16, 2011
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania... Read More
A Higher Level Of Aromatase In Breast Tissue Is More Dangerous Than Excess Production Of Estrogen Receptors
Aug 15, 2011
Could some women who naturally produce excess aromatase in their breasts have an increased risk of developing breast cancer? Results of a new animal study suggests that may be the case, say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center... Read More
Common Class Of Pain Drugs Reduces Severity Of Postpartum Breast Cancers
Aug 15, 2011
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models... Read More
Stem Cell Mobilization Therapy Found To Be Safe For Bone Marrow Donors
Aug 15, 2011
According to a study published in Blood, the Journal of the American Society of Hematology (ASH), researchers have reported that administration of granulocyte colony-stimulating factor (G-CSF), a drug that releases stem cells from the bone marrow into the blood, is unlikely to put healthy stem cell donors at risk for later development of abnormalities involving loss or gains ... Read More
Pharmacist-Directed Anticoagulation Service Improves Care Coordination
Aug 14, 2011
A pharmacist-directed anticoagulation service improves the coordination of care from the hospital to an outpatient clinic for patients treated with the anticoagulant drug warfarin, according to a Henry Ford Hospital study... Read More
China Medical Technologies Announces SFDA Approvals For Its Prostate Cancer FISH Detection Kit And TOP2A FISH Detection Kit
Aug 13, 2011
China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced that it has received approvals for its prostate cancer FISH detection kit and Topoisomerase 2-alpha ("TOP2A") FISH detection kit from the State Food and Drug Administration (the "SFDA") of the People's Republic of China... Read More
New Prostate Cancer Urine Test
Aug 13, 2011
Prostate Specific Antigen (PSA) screening is the universal standard for early detection of prostate cancer in men. The medical community, and even the press, routinely urge men to begin PSA testing at age 50, and even earlier age 40 for high risk men, including African Americans or those with a family history of prostate cancer. Dr... Read More
New Treatment Option For Advanced Prostate Cancer
Aug 13, 2011
Prostate cancer that has become resistant to hormone treatment and that does not respond to radiation or chemotherapy requires new methods of treatment. By attacking stem cell-like cells in prostate cancer, researchers at Lund University are working on a project to develop a new treatment option... Read More
Previous Page Next Page